跳至主要内容
临床试验/ISRCTN58025172
ISRCTN58025172
进行中(未招募)
4 期

The EPIgenetic consequences in children of Volatile-based anaesthesia and surgery, with high or low OXygen exposure (EPI-VOX) – A single centre, double-blinded, randomised, feasibility trial

niversity Hospital Southampton NHS Foundation Trust0 个研究点目标入组 10 人2023年5月22日

概览

阶段
4 期
干预措施
未指定
疾病 / 适应症
Children aged under 3 years old and undergoing general anaesthesia and surgery for developmental dysplasia of the hip.
发起方
niversity Hospital Southampton NHS Foundation Trust
入组人数
10
状态
进行中(未招募)
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2023年5月22日
结束日期
2025年6月30日
最后更新
2年前
研究类型
Interventional
性别
All

研究者

发起方
niversity Hospital Southampton NHS Foundation Trust

入排标准

入选标准

  • 1\. Age \=6 months and \=3 years at time of initial operation
  • 2\. Undergoing surgical management of DDH (unilateral or bilateral)
  • 3\. Completed informed consent form (ICF) from legal representative (LR (this is the person who is empowered to give informed consent on behalf of a participant. For most children this will be one or both parents. This may also be a guardian or custodian with legal custody)).

排除标准

  • 1\. Legal representative (LR) unable to provide completed ICF
  • 2\. Withdrawal of consent at any stage
  • 3\. Previous exposure to general anaesthesia at any stage of life, including in\-utero (through maternal exposure at any stage until delivery)
  • 4\. Neurodevelopmental/neurodisability diagnosis (given or under investigation) from a paediatric service including autistic spectrum disorder (ASD), attention deficit disorder (ADHD), traumatic brain injury (TBI), down’s syndrome, cerebral palsy, epilepsy
  • 5\. Chronic respiratory diagnosis (given or under investigation) from a paedatric service, including bronchopulmonary dysplasia and cystic fibrosis with pulmonary manifestations, but excluding asthma
  • 6\. Clinical opinion that randomising the child’s oxygen exposure would be unsafe
  • 7\. Clinical opinion that the use of a volatile anaesthesic agent would be unsafe

结局指标

主要结局

未指定

相似试验